claim
Chemotherapeutic agents including etoposide (NCT00878449), irinotecan (NCT01009073), cisplatin (NCT00878449), paclitaxel (NCT00891605), docetaxel (NCT00888108), and gemcitabine (NCT00887757) have been tested in combination with navitoclax to treat various cancers.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (1)
- cisplatin concept